Regulatory T Cells Control Effector T Cell Inflammation in Human Prediabetes

Overview

Journal Diabetes

Specialty Endocrinology

Date 2021 Nov 5

PMID 34737186

Citations 9

Authors

Rui Liu

Gabriella H Pugh

Erin Tevonian

Katherine Thompson

Douglas A Lauffenburger

Philip A Kern

Barbara S Nikolajczyk

Affiliations

Soon will be listed here.

Abstract

A disparate array of plasma/serum markers provides evidence for chronic inflammation in human prediabetes, a condition that is most closely replicated by standard mouse models of obesity and metaflammation. These remain largely nonactionable and contrast with our rich understanding of inflammation in human type 2 diabetes. New data show that inflammatory profiles produced by CD4+ T cells define human prediabetes as a unique inflammatory state. Regulatory T cells (Treg) control mitochondrial function and cytokine production by CD4+ effector T cells (Teff) in prediabetes and type 2 diabetes by supporting T helper (Th)17 or Th1 cytokine production, respectively. These data suggest that Treg control of Teff metabolism regulates inflammation differentially in prediabetes compared with type 2 diabetes. Queries of genes that impact mitochondrial function or pathways leading to transcription of lipid metabolism genes identified the fatty acid importer CD36 as highly expressed in Treg but not Teff from subjects with prediabetes. Pharmacological blockade of CD36 in Treg from subjects with prediabetes decreased Teff production of the Th17 cytokines that differentiate overall prediabetes inflammation. We conclude that Treg control CD4+ T cell cytokine profiles through mechanisms determined, at least in part, by host metabolic status. Furthermore, Treg CD36 uniquely promotes Th17 cytokine production by Teff in prediabetes.

Citing Articles

Immunometabolic Changes Following Gastric Bypass and Sleeve Gastrectomy: A Comparative Study.

Rivera-Carranza T, Azaola-Espinosa A, Bojalil-Parra R, Zuniga-Leon E, Leon-Tellez-Giron A, Rojano-Rodriguez M Obes Surg. 2025; 35(2):481-495.

PMID: 39794663 PMC: 11836204. DOI: 10.1007/s11695-024-07598-3.

T cell metabolism in kidney immune homeostasis.

Liu Z, Dai B, Bao J, Pan Y Front Immunol. 2024; 15:1498808.

PMID: 39737193 PMC: 11684269. DOI: 10.3389/fimmu.2024.1498808.

Fasting and Glucose Metabolism Differentially Impact Peripheral Inflammation in Human Type 2 Diabetes.

Kalantar G, Saraswat S, SantaCruz-Calvo S, Gholamrezaeinejad F, Javidan A, Agrawal M Nutrients. 2024; 16(10.

PMID: 38794641 PMC: 11124302. DOI: 10.3390/nu16101404.

T cells in obesity-associated inflammation: The devil is in the details.

Valentine Y, Nikolajczyk B Immunol Rev. 2024; 324(1):25-41.

PMID: 38767210 PMC: 11694249. DOI: 10.1111/imr.13354.

Metabolic Alteration Bridging the Prediabetic State and Colorectal Cancer.

Colloca A, Donisi I, Anastasio C, Balestrieri M, DOnofrio N Cells. 2024; 13(8.

PMID: 38667278 PMC: 11049175. DOI: 10.3390/cells13080663.

References

Defuria J, Belkina A, Jagannathan-Bogdan M, Snyder-Cappione J, Carr J, Nersesova Y . B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proc Natl Acad Sci U S A. 2013; 110(13):5133-8. PMC: 3612635. DOI: 10.1073/pnas.1215840110. View

Brahimaj A, Ligthart S, Ghanbari M, Ikram M, Hofman A, Franco O . Novel inflammatory markers for incident pre-diabetes and type 2 diabetes: the Rotterdam Study. Eur J Epidemiol. 2017; 32(3):217-226. PMC: 5380703. DOI: 10.1007/s10654-017-0236-0. View

Jagannathan-Bogdan M, McDonnell M, Shin H, Rehman Q, Hasturk H, Apovian C . Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes. J Immunol. 2010; 186(2):1162-72. PMC: 3089774. DOI: 10.4049/jimmunol.1002615. View

Nicholas D, Proctor E, Agrawal M, Belkina A, Van Nostrand S, Panneerseelan-Bharath L . Fatty Acid Metabolites Combine with Reduced β Oxidation to Activate Th17 Inflammation in Human Type 2 Diabetes. Cell Metab. 2019; 30(3):447-461.e5. PMC: 8506657. DOI: 10.1016/j.cmet.2019.07.004. View

Su C, Chen C, Li Y, Long S, Massey W, Vijaya Kumar D . Helminth infection protects against high fat diet-induced obesity via induction of alternatively activated macrophages. Sci Rep. 2018; 8(1):4607. PMC: 5854586. DOI: 10.1038/s41598-018-22920-7. View

Laparra A, Tricot S, Le Van M, Damouche A, Gorwood J, Vaslin B . The Frequencies of Immunosuppressive Cells in Adipose Tissue Differ in Human, Non-human Primate, and Mouse Models. Front Immunol. 2019; 10:117. PMC: 6371887. DOI: 10.3389/fimmu.2019.00117. View

Hussaarts L, Garcia-Tardon N, van Beek L, Heemskerk M, Haeberlein S, van der Zon G . Chronic helminth infection and helminth-derived egg antigens promote adipose tissue M2 macrophages and improve insulin sensitivity in obese mice. FASEB J. 2015; 29(7):3027-39. DOI: 10.1096/fj.14-266239. View

Coort S, Willems J, Coumans W, van der Vusse G, Bonen A, Glatz J . Sulfo-N-succinimidyl esters of long chain fatty acids specifically inhibit fatty acid translocase (FAT/CD36)-mediated cellular fatty acid uptake. Mol Cell Biochem. 2002; 239(1-2):213-9. View

Kishore M, Cheung K, Fu H, Bonacina F, Wang G, Coe D . Regulatory T Cell Migration Is Dependent on Glucokinase-Mediated Glycolysis. Immunity. 2017; 47(5):875-889.e10. PMC: 5714502. DOI: 10.1016/j.immuni.2017.10.017. View

10.

Glatz J, Luiken J, Bonen A . Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease. Physiol Rev. 2010; 90(1):367-417. DOI: 10.1152/physrev.00003.2009. View

11.

Wang H, Franco F, Tsui Y, Xie X, Trefny M, Zappasodi R . CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors. Nat Immunol. 2020; 21(3):298-308. PMC: 7043937. DOI: 10.1038/s41590-019-0589-5. View

12.

Chinen T, Kannan A, Levine A, Fan X, Klein U, Zheng Y . An essential role for the IL-2 receptor in T cell function. Nat Immunol. 2016; 17(11):1322-1333. PMC: 5071159. DOI: 10.1038/ni.3540. View

13.

Angela M, Endo Y, Asou H, Yamamoto T, Tumes D, Tokuyama H . Fatty acid metabolic reprogramming via mTOR-mediated inductions of PPARγ directs early activation of T cells. Nat Commun. 2016; 7:13683. PMC: 5141517. DOI: 10.1038/ncomms13683. View

14.

Feuerer M, Herrero L, Cipolletta D, Naaz A, Wong J, Nayer A . Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med. 2009; 15(8):930-9. PMC: 3115752. DOI: 10.1038/nm.2002. View

15.

De Rosa V, Galgani M, Porcellini A, Colamatteo A, Santopaolo M, Zuchegna C . Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants. Nat Immunol. 2015; 16(11):1174-84. PMC: 4868085. DOI: 10.1038/ni.3269. View

16.

Nicholas D, Proctor E, Raval F, Ip B, Habib C, Ritou E . Advances in the quantification of mitochondrial function in primary human immune cells through extracellular flux analysis. PLoS One. 2017; 12(2):e0170975. PMC: 5298256. DOI: 10.1371/journal.pone.0170975. View

17.

Luc K, Schramm-Luc A, Guzik T, Mikolajczyk T . Oxidative stress and inflammatory markers in prediabetes and diabetes. J Physiol Pharmacol. 2020; 70(6). DOI: 10.26402/jpp.2019.6.01. View

18.

Johnson M, Wolf M, Madden M, Andrejeva G, Sugiura A, Contreras D . Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism. Cell. 2018; 175(7):1780-1795.e19. PMC: 6361668. DOI: 10.1016/j.cell.2018.10.001. View

19.

Procaccini C, Carbone F, Silvestre D, Brambilla F, De Rosa V, Galgani M . The Proteomic Landscape of Human Ex Vivo Regulatory and Conventional T Cells Reveals Specific Metabolic Requirements. Immunity. 2016; 44(2):406-21. PMC: 4760097. DOI: 10.1016/j.immuni.2016.01.028. View

20.

Gogg S, Nerstedt A, Boren J, Smith U . Human adipose tissue microvascular endothelial cells secrete PPARγ ligands and regulate adipose tissue lipid uptake. JCI Insight. 2019; 4(5). PMC: 6483600. DOI: 10.1172/jci.insight.125914. View